0
What does the future hold for Quality Management as smart automation offers new ways to monitor and pre-emptively intervene in pharmaceutical production? Late last year, a panel of experts from Merck, Syneos Health and Accenture, chaired by James Kelleher, CEO of Generis, debated the subject.
The participants were:
- Dr. Heiner Niessen, Head of Application Technology Quality & Compliance at Merck
- Peter Brandstetter, Quality and Regulatory expert at Accenture
- James Man, Quality subject expert and R&D Advisory Managing Director at Syneos Health.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox
